VU 0364770
98%
- Product Code: 110843
CAS:
61350-00-3
| Molecular Weight: | 232.67 g./mol | Molecular Formula: | C₁₂H₉ClN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
VU 0364770 is primarily used in research settings as a potent and selective positive allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 4 (mGluR4). Its application is significant in neuroscience studies, particularly in investigating the role of mGluR4 in the central nervous system. Researchers utilize this compound to explore potential therapeutic strategies for neurological disorders such as Parkinson's disease, anxiety, and epilepsy. By enhancing mGluR4 activity, VU 0364770 helps in understanding the modulation of glutamate signaling, which is crucial for synaptic plasticity and neuronal communication. This makes it a valuable tool in preclinical studies aimed at developing novel treatments for brain-related conditions.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Light Yellow To Yellow Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $496.57 |
+
-
|
VU 0364770
VU 0364770 is primarily used in research settings as a potent and selective positive allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 4 (mGluR4). Its application is significant in neuroscience studies, particularly in investigating the role of mGluR4 in the central nervous system. Researchers utilize this compound to explore potential therapeutic strategies for neurological disorders such as Parkinson's disease, anxiety, and epilepsy. By enhancing mGluR4 activity, VU 0364770 helps in understanding the modulation of glutamate signaling, which is crucial for synaptic plasticity and neuronal communication. This makes it a valuable tool in preclinical studies aimed at developing novel treatments for brain-related conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :